user

Accredo - An Express Scripts Company

Hospitals and Health Care
  • image
    Jeffrey Shulka Key Account Management | Multi Presidents Club Winner | Specialty Pharmaceutical | Rare Disease| People Leader
    • New Freedom, Pennsylvania, United States
    • Rising Star
    View Details
  • image
    Mirette Hanalla (DPh) Staff Pharmacist at Accredo - An Express Scripts Company
    • Collierville, Tennessee, United States
    • Rising Star
    View Details
  • image
    Susan Shomaker Director, Hemophilia 340B and Rare Disease at Accredo - An Express Scripts Company
    • Haymarket, Virginia, United States
    • Rising Star
    View Details
  • image
    Terrance Wilkins Operating Effectiveness Senior Manager at Cigna
    • Richardson, Texas, United States
    • Rising Star
    View Details
  • image
    Ashlie Mothershead Deilgat Accredo Account Director in Oncology - An Express Scripts Company
    • Nashville Metropolitan Area
    • Rising Star
    View Details

Overview

Headquartered in Memphis, Tennessee, Accredo Health Group, Inc., provides specialty pharmacy and related services for patients with certain complex and chronic conditions through our unique Therapeutic Resource Centers. Accredo is a wholly owned subsidiary of Express Scripts. Accredo’s Therapeutic Resource Centers are segmented by therapy and provide targeted therapy management programs for the following therapeutic areas: Rheumatoid arthritis Multiple sclerosis Oncology Hepatitis C Immune disorders Pulmonary arterial hypertension Hemophilia Other specialty therapies with dedicated care teams (RSV, growth deficiencies, etc.) Our services cover the range of needs posed by specialty pharmacy care. Our pharmacists and other healthcare professionals talk frequently with patients over the phone, helping them follow their treatment and educating them about their condition. And our reimbursement specialists provide b enefits research services, with an explanation to the patient or patient’s caregiver of any financial responsibility he/she may have plus prior authorization determination.